Block Listing Six Monthly Return

RNS Number : 7694L

Ergomed plc

02 January 2019

 

BLOCK LISTING SIX MONTHLY RETURN

Date: 2 January 2019

Name of applicant:		Ergomed plc
Name of scheme:		Ergomed plc Long Term Incentive Plan
Period of return:	From:	2 July 2018	To:	31 December 2018
Balance of unallotted securities under scheme(s) from previous return:		1,800,000 (original admission)
Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):		nil
Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):		55,000
Equals:  Balance under scheme(s) not yet issued/allotted at end of period:		1,745,000
Number and class of securities originally admitted and the date of admission		1,800,000 ordinary shares of 1p each - 2 July 2018
Total number of securities in issue at the end of the period		45,016,438 ordinary shares of 1p each

Name of contact:	Nick Blech - Deputy CFO
Telephone number of contact:	[phone]

 Enquiries:

Ergomed plc	Tel: [phone]
Stephen Stamp (Chief Executive Officer)
Stuart Jackson (Chief Financial Officer)
Numis Securities Limited	Tel: [phone]
Michael Meade / Freddie Barnfield (Nominated Adviser)
James Black (Broker)
Consilium Strategic Communications - for UK enquiries	Tel: [phone]
Chris Gardner / Mary-Jane Elliott Matthew Neal / Olivia Manser	[e-mail]
MC-Services - for Continental European enquiries	Tel: [phone]
Anne Hennecke

About Ergomed plc

Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed's fast-growing, profitable services offering encompasses a complete suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand, in addition to a full range of high quality contract research and trial management services (CRO). Leveraging its CRO expertise, Ergomed also has a drug development portfolio of co-development partnerships and wholly-owned programmes. For further information, visit: http://ergomedplc.com

 

END

 

 

BLRFEWFWAFASEEE